Capsular Tension Ring With Hydrophilic Versus Hydrophobic Intraocular Lenses
CTR-IOL-3ARM
Outcomes of Hydrophilic Intraocular Lens Implantation With and Without a Capsular Tension Ring Versus Hydrophobic Intraocular Lens Implantation Alone: A Randomized Controlled Trial
1 other identifier
interventional
600
1 country
1
Brief Summary
This study compares three approaches to cataract surgery. Cataract surgery involves removing the eye's cloudy natural lens and replacing it with an artificial intraocular lens (IOL) to restore clear vision. IOLs are made from different materials, most commonly a "hydrophilic" (water-attracting) acrylic or a "hydrophobic" (water-repelling) acrylic. Hydrophilic lenses are generally easier and less expensive to use, but have been linked in past research to a higher chance of the lens capsule becoming cloudy again after surgery (posterior capsule opacification, or PCO), sometimes requiring a follow-up laser treatment. Hydrophobic lenses tend to have lower rates of this problem but can cost more. A capsular tension ring (CTR) is a small flexible ring that can be placed inside the eye at the time of surgery to help hold the lens capsule in a stable, round shape. This study asks whether adding a CTR when a hydrophilic lens is used can reduce the disadvantages usually seen with that lens material. 600 adult patients (ages 50-80) undergoing cataract surgery at three hospitals in Egypt were randomly assigned to one of three groups: (1) a hydrophilic lens plus a CTR, (2) a hydrophobic lens alone (the common comparison approach), or (3) a hydrophilic lens alone without a CTR. Patients were followed for 24 months, and researchers compared vision, glasses prescription accuracy, lens position, capsule clouding, need for laser treatment, and surgical complications between the groups. The results showed that adding a CTR to a hydrophilic lens produced results very similar to using a hydrophobic lens alone. In contrast, using a hydrophilic lens without a CTR resulted in worse vision, less accurate glasses prescriptions, more lens shifting or tilting, more capsule clouding, a higher need for laser treatment, and more complications compared with the hydrophobic lens. These findings suggest that adding a CTR may be a simple, low-cost way to improve outcomes when a hydrophilic lens is used for cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2026
CompletedFirst Submitted
Initial submission to the registry
September 21, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedSeptember 25, 2026
September 1, 2026
3.4 years
September 21, 2026
September 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Best-corrected visual acuity (BCVA)
Best-corrected visual acuity measured in logMAR units, assessed longitudinally at 1, 3, 6, 12, 18, and 24 months, with between-group comparison at 24 months as the primary efficacy endpoint.
24 months postoperatively
Secondary Outcomes (1)
Manifest spherical equivalent refractive error
24 months postoperatively
Study Arms (3)
U.S. flag An official website of the United States government Here's how you know Skip to main page
EXPERIMENTALPhacoemulsification with implantation of a hydrophilic acrylic intraocular lens (Eyecryl, Biotech Healthcare, India) combined with insertion of a polymethyl methacrylate capsular tension ring (Auroring CTR 11, Aurolab, India).
Group B: Hydrophobic IOL alone
ACTIVE COMPARATORPhacoemulsification with implantation of a hydrophobic acrylic intraocular lens (AcrySof IQ, Alcon Laboratories, USA), without a capsular tension ring.
Group C: Hydrophilic IOL alone
EXPERIMENTALPhacoemulsification with implantation of the same hydrophilic acrylic intraocular lens used in Group A (Eyecryl, Biotech Healthcare, India), without capsular tension ring insertion.
Interventions
Foldable hydrophilic acrylic intraocular lens implanted in the capsular bag following phacoemulsification.
Polymethyl methacrylate capsular tension ring (overall diameter 13.0 mm, compressed diameter 11.0 mm) inserted into the capsular bag to distribute equatorial zonular forces and maintain capsular bag contour.
Foldable hydrophobic acrylic intraocular lens implanted in the capsular bag following phacoemulsification.
Eligibility Criteria
You may qualify if:
- Age 50-80 years
- Visually significant age-related cataract, defined as nuclear opacity grade \>=3 according to the Lens Opacities Classification System III (LOCS III), graded preoperatively under standardized mydriasis via slit-lamp biomicroscopy
- Clear cornea
- Adequate pupillary dilation
- Anatomically normal capsular bag with no evidence of zonular weakness
- No ocular comorbidities expected to affect visual or refractive outcomes
You may not qualify if:
- Previous intraocular surgery
- Ocular trauma
- Pseudoexfoliation syndrome
- Posterior polar cataract
- Zonular instability
- Complicated cataract
- Active intraocular inflammation
- Retinal or optic nerve pathology
- Anticipated need for additional capsular support devices beyond the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Study Sites (1)
Benha University
Banhā, Benha, 13111, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors and data analysts were blinded to treatment allocation. Operating surgeons could not be masked due to the nature of the surgical intervention (visible IOL material and presence/absence of a capsular tension ring during implantation).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Ophthalmology
Study Record Dates
First Submitted
September 21, 2026
First Posted
September 25, 2026
Study Start
December 15, 2022
Primary Completion
May 15, 2026
Study Completion
May 15, 2026
Last Updated
September 25, 2026
Record last verified: 2026-09